Recall Z-0846-2020— Vitreq Bv
Class II · Terminated
Class II FDA medical device recall by Vitreq Bv, initiated 2019-12-17, terminated 2020-12-09. FDA's recall record names no specific 510(k) clearance for this event. Product: (1) VitreQ 23G BF Blunt Needles-BF23.D51 GTIN#: 8719214221126 (2) VitreQ 23G BF Brush Needles-BF23.D52 GTIN#: 8719214221140. Reason: Microscopic tears of the sterile pouch may compromise sterility.
- Recalling firm
- Vitreq Bv
- Classification
- Class II
- Status
- Terminated
- Initiated
- 2019-12-17
- Terminated
- 2020-12-09
- Firm location
- Vierpolders, N/A, Netherlands
Product description
(1) VitreQ 23G BF Blunt Needles-BF23.D51 GTIN#: 8719214221126 (2) VitreQ 23G BF Brush Needles-BF23.D52 GTIN#: 8719214221140
Reason for recall
Microscopic tears of the sterile pouch may compromise sterility
Data sourced from openFDA. This site is unofficial and independent of the FDA.